A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains.
Animals
Antigenic Variation
/ immunology
Antigens, Viral
/ immunology
Chickens
Hemagglutinin Glycoproteins, Influenza Virus
/ immunology
Humans
Influenza A Virus, H5N1 Subtype
/ classification
Influenza Vaccines
/ immunology
Influenza in Birds
/ prevention & control
Influenza, Human
/ prevention & control
Phylogeny
Vaccines, Virus-Like Particle
/ immunology
Vaccinology
COBRA
Chickens
H5N1
Influenza
Pre-pandemic
Universal vaccine
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
17 04 2019
17 04 2019
Historique:
received:
05
10
2018
revised:
05
03
2019
accepted:
11
03
2019
pubmed:
25
3
2019
medline:
15
8
2020
entrez:
26
3
2019
Statut:
ppublish
Résumé
Since the first identification of the H5N1 Goose/Guangdong lineage in 1996, this highly pathogenic avian influenza virus has spread worldwide, becoming endemic in domestic poultry. Sporadic transmission to humans has raised concerns of a potential pandemic and underscores the need for a broad cross-protective influenza vaccine. Here, we tested our previously described methodology, termed Computationally Optimized Broadly Reactive Antigen (COBRA), to generate a novel hemagglutinin (HA) gene, termed COBRA-2, that was based on H5 HA sequences from 2005 to 2006. The COBRA-2 HA virus-like particle (VLP) vaccines were used to vaccinate chickens and the immune responses were compared to responses elicited by VLP's expressing HA from A/whooper swan/Mongolia/244/2005 (WS/05), a representative 2005 vaccine virus from clade 2.2. To support this evaluation a hemagglutination inhibition (HAI) breadth panel was developed consisting of phylogenetically and antigenically diverse H5 strains in circulation from 2005 to 2006, as well as recent drift variants (2008 - 2014). We found that the COBRA-2 VLP vaccines elicited robust HAI titers against this entire breadth panel, whereas the VLP vaccine based upon the recommended WS/05 HA only elicited HAI responses against a subset of strains. Furthermore, while all vaccines protected chickens against challenge with the WS/05 virus, only the human COBRA-2 VLP vaccinated birds were protected (80%) against a recent drifted clade 2.3.2.1B, A/duck/Vietnam/NCVD-672/2011 (VN/11) virus. This is the first report to demonstrate seroprotective antibody responses against genetically diverse clades and sub-clades of H5 viruses and protective efficacy against a recent drifted variant using a globular head based design strategy.
Identifiants
pubmed: 30905528
pii: S0264-410X(19)30336-6
doi: 10.1016/j.vaccine.2019.03.018
pii:
doi:
Substances chimiques
Antigens, Viral
0
Hemagglutinin Glycoproteins, Influenza Virus
0
Influenza Vaccines
0
Vaccines, Virus-Like Particle
0
hemagglutinin, avian influenza A virus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2369-2376Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.